Anne Whitehurst, MD | |
971 Lakeland Dr Ste 954, Jackson, MS 39216-4609 | |
(601) 200-4714 | |
(601) 200-4718 |
Full Name | Anne Whitehurst |
---|---|
Gender | Female |
Speciality | Internal Medicine - Infectious Disease |
Location | 971 Lakeland Dr Ste 954, Jackson, Mississippi |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689622318 | NPI | - | NPPES |
0121854 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 12287 (Mississippi) | Primary |
Entity Name | St. Dominic Medical Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407920549 PECOS PAC ID: 0446303168 Enrollment ID: O20090728000821 |
News Archive
Fujitsu Frontech North America Inc., a leading supplier of innovative computer products including peripherals and biometric security solutions, today announced that Holy Name Hospital in Teaneck, N.J. is the first hospital in New Jersey to implement the Fujitsu PalmSecureā¢ palm vein authentication technology for patient registration and identification. The Fujitsu PalmSecure biometric solution integrates into Holy Name's new Palm First registration system to bolster security of medical records and enhance the overall patient experience.
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings.
Researchers have discovered that many popular e-cigarette products are contaminated with microbial toxins that are known to cause a range of health problems
In their search for new ways to treat cancer, many scientists are using a high-tech process called genome sequencing to hunt for genetic mutations that encourage tumor cells to thrive.
BioMarin Pharmaceutical Inc. today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has completed review of the Clinical Trial Application (CTA) and issued a notice of acceptance for the Phase 3 trial of N-acetylgalactosamine 6-sulfatase (GALNS) for the treatment of Mucopolysaccharidosis IVA (MPS IVA). The company expects to initiate the Phase 3 pivotal trial early in the first quarter of 2011.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Anne Whitehurst, MD Po Box 23666, Jackson, MS 39225-3666 Ph: (601) 200-4749 | Anne Whitehurst, MD 971 Lakeland Dr Ste 954, Jackson, MS 39216-4609 Ph: (601) 200-4714 |
News Archive
Fujitsu Frontech North America Inc., a leading supplier of innovative computer products including peripherals and biometric security solutions, today announced that Holy Name Hospital in Teaneck, N.J. is the first hospital in New Jersey to implement the Fujitsu PalmSecureā¢ palm vein authentication technology for patient registration and identification. The Fujitsu PalmSecure biometric solution integrates into Holy Name's new Palm First registration system to bolster security of medical records and enhance the overall patient experience.
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings.
Researchers have discovered that many popular e-cigarette products are contaminated with microbial toxins that are known to cause a range of health problems
In their search for new ways to treat cancer, many scientists are using a high-tech process called genome sequencing to hunt for genetic mutations that encourage tumor cells to thrive.
BioMarin Pharmaceutical Inc. today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has completed review of the Clinical Trial Application (CTA) and issued a notice of acceptance for the Phase 3 trial of N-acetylgalactosamine 6-sulfatase (GALNS) for the treatment of Mucopolysaccharidosis IVA (MPS IVA). The company expects to initiate the Phase 3 pivotal trial early in the first quarter of 2011.
› Verified 5 days ago
Graves Crawley Stubblefield Jr., M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 406 Briarwood Dr, Jackson, MS 39206 Phone: 601-991-1933 Fax: 601-978-3844 | |
Dr. Rebecca Chick Pace, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St, Suite 500, Jackson, MS 39202 Phone: 601-352-2273 Fax: 601-714-3415 | |
Jewelian Akbar Baig, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr Ste 356, Jackson, MS 39216 Phone: 601-200-4644 Fax: 601-200-4645 | |
Jo P Deal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 766 Lakeland Dr, A, Jackson, MS 39216 Phone: 601-368-3440 Fax: 601-368-3441 | |
Caryl P. Sumrall, FNP Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Department Of Medicine/division Of General Internal Med, Jackson, MS 39216 Phone: 601-984-5660 | |
Meghan Alford Luter, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5532 | |
Tammy H Young, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1227 N State St, Ste 101, Jackson, MS 39202 Phone: 601-355-2485 Fax: 601-353-1463 |